960404-86-8 ((Dapagliflozin impurity)

CAS号:
960404-86-8
英文名称:
Dapagliflozin impurity
分子式:
C21H25ClO7
分子量:
424.872006177902
简介:
Dapagliflozin impurity 是 Dapagliflozin 的对映异构体,Dapagliflozin 是一种钠葡萄糖转运蛋白 2 (sodium-glucose transporter 2) 抑制剂。

Dapagliflozin impurity(960404-86-8)名称与标识符

名称

中文别名:
达格列净杂质10;
英文别名:
Dapagliflozin Hydroxy impurity;(2S,3R,4S,5S,6R)-2-(4-Chloro-3-(4-ethoxybenzyl)phenyl)-6-(hydroxymethyl)tetrahydro-2H-pyran-2,3,4,5-tetraol;(2S)-2-[4-Chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-6-(hydroxymethyl)oxane-2,3,4,5-tetrol;1-C-[4-Chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-α-D-glucopyranose (ACI);D;Dapagliflozin Impurity 10;Dapagliflozin impurity;

标识符

InChIKey:
KYDGWGYAUCJZDV-ALAWOQLPSA-N
Inchi:
1S/C21H25ClO7/c1-2-28-15-6-3-12(4-7-15)9-13-10-14(5-8-16(13)22)21(27)20(26)19(25)18(24)17(11-23)29-21/h3-8,10,17-20,23-27H,2,9,11H2,1H3/t17?,18?,19?,20?,21-/m0/s1
SMILES:
ClC1C=CC(=CC=1CC1C=CC(=CC=1)OCC)[C@]1(C(C(C(C(CO)O1)O)O)O)O

Dapagliflozin impurity(960404-86-8)物化性质

计算特性

  • 氢键供体数量 : 5
  • 氢键受体数量 : 7
  • 可旋转化学键数量 : 6
  • 重原子数量 : 29
  • 复杂度 : 515
  • 拓扑分子极性表面积 : 120

Dapagliflozin impurity(960404-86-8)推荐厂家 更多厂家(15)

Dapagliflozin impurity(960404-86-8)合成路线

合成路线:1 步
反应条件:
参考文献:
Method for preparing dapagliflozin
, China, , ,
合成路线:1 步
反应条件:
参考文献:
Process for the preparation of dapagliflozin and its solvate thereof
, World Intellectual Property Organization, , ,
合成路线:1 步
反应条件:
参考文献:
Amorphous form of dapagliflozin propylene glycol solvate and premix of dapagliflozin propylene glycol and process for preparation of the same
, India, , ,
合成路线:1 步
反应条件:
参考文献:
Crystalline solvates of amino acid complexes with (1S)-1,5-anhydro-L-C-(3-((phenyl)methyl)phenyl)-D-glucitol were prepared as SGLT2 inhibitors for the treatment of diabetes
, United States, , ,
合成路线:1 步
参考文献:
Preparation of 1-C-substituted phenyl glucopyranoside
, China, , ,
合成路线:1 步
参考文献:
Crystalline solvates of amino acid complexes with (1S)-1,5-anhydro-L-C-(3-((phenyl)methyl)phenyl)-D-glucitol were prepared as SGLT2 inhibitors for the treatment of diabetes
, World Intellectual Property Organization, , ,
合成路线:1 步
反应条件:
参考文献:
Preparation of SGLT2 inhibitors
, China, , ,